Global Drugs to Treat Chronic Kidney Disease Supply, Demand and Key Producers, 2023-2029

November 2023 | 116 pages | ID: G790203EC96BEN
GlobalInfoResearch

Abstracts

The global Drugs to Treat Chronic Kidney Disease market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Drugs to Treat Chronic Kidney Disease demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Drugs to Treat Chronic Kidney Disease, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drugs to Treat Chronic Kidney Disease that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Drugs to Treat Chronic Kidney Disease total market, 2018-2029, (USD Million)

Global Drugs to Treat Chronic Kidney Disease total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Drugs to Treat Chronic Kidney Disease total market, key domestic companies and share, (USD Million)

Global Drugs to Treat Chronic Kidney Disease revenue by player and market share 2018-2023, (USD Million)

Global Drugs to Treat Chronic Kidney Disease total market by Type, CAGR, 2018-2029, (USD Million)

Global Drugs to Treat Chronic Kidney Disease total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Drugs to Treat Chronic Kidney Disease market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc and Eli Lilly and Company, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drugs to Treat Chronic Kidney Disease market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Drugs to Treat Chronic Kidney Disease Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Drugs to Treat Chronic Kidney Disease Market, Segmentation by Type

• Calcimimetics
• Vitamin D
• Sterols
• Potassium Binders
• Calcium-Based Phosphate Binders

Global Drugs to Treat Chronic Kidney Disease Market, Segmentation by Application

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Companies Profiled:

• Pfizer Inc.
• Johnson & Johnson
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Sanofi SA
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Eli Lilly and Company
• C.H. Boehringer Sohn AG & Co. KG
• Amgen Inc.
• Novo Nordisk A/S
• Teva Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Takeda Pharmaceutical Company Limited

Key Questions Answered

1. How big is the global Drugs to Treat Chronic Kidney Disease market?

2. What is the demand of the global Drugs to Treat Chronic Kidney Disease market?

3. What is the year over year growth of the global Drugs to Treat Chronic Kidney Disease market?

4. What is the total value of the global Drugs to Treat Chronic Kidney Disease market?

5. Who are the major players in the global Drugs to Treat Chronic Kidney Disease market?

Contents

1 SUPPLY SUMMARY

1.1 Drugs to Treat Chronic Kidney Disease Introduction
1.2 World Drugs to Treat Chronic Kidney Disease Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Drugs to Treat Chronic Kidney Disease Total Market by Region (by Headquarter Location)
  1.3.1 World Drugs to Treat Chronic Kidney Disease Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
  1.3.3 China Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
  1.3.4 Europe Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
  1.3.5 Japan Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
  1.3.6 South Korea Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
  1.3.7 ASEAN Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
  1.3.8 India Drugs to Treat Chronic Kidney Disease Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Drugs to Treat Chronic Kidney Disease Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Drugs to Treat Chronic Kidney Disease Major Market Trends

2 DEMAND SUMMARY

2.1 World Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029)
2.2 World Drugs to Treat Chronic Kidney Disease Consumption Value by Region
  2.2.1 World Drugs to Treat Chronic Kidney Disease Consumption Value by Region (2018-2023)
  2.2.2 World Drugs to Treat Chronic Kidney Disease Consumption Value Forecast by Region (2024-2029)
2.3 United States Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029)
2.4 China Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029)
2.5 Europe Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029)
2.6 Japan Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029)
2.7 South Korea Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029)
2.8 ASEAN Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029)
2.9 India Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029)

3 WORLD DRUGS TO TREAT CHRONIC KIDNEY DISEASE COMPANIES COMPETITIVE ANALYSIS

3.1 World Drugs to Treat Chronic Kidney Disease Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Drugs to Treat Chronic Kidney Disease Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Drugs to Treat Chronic Kidney Disease in 2022
  3.2.3 Global Concentration Ratios (CR8) for Drugs to Treat Chronic Kidney Disease in 2022
3.3 Drugs to Treat Chronic Kidney Disease Company Evaluation Quadrant
3.4 Drugs to Treat Chronic Kidney Disease Market: Overall Company Footprint Analysis
  3.4.1 Drugs to Treat Chronic Kidney Disease Market: Region Footprint
  3.4.2 Drugs to Treat Chronic Kidney Disease Market: Company Product Type Footprint
  3.4.3 Drugs to Treat Chronic Kidney Disease Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Drugs to Treat Chronic Kidney Disease Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Drugs to Treat Chronic Kidney Disease Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Drugs to Treat Chronic Kidney Disease Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Drugs to Treat Chronic Kidney Disease Consumption Value Comparison
  4.2.1 United States VS China: Drugs to Treat Chronic Kidney Disease Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Drugs to Treat Chronic Kidney Disease Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Drugs to Treat Chronic Kidney Disease Companies and Market Share, 2018-2023
  4.3.1 United States Based Drugs to Treat Chronic Kidney Disease Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Drugs to Treat Chronic Kidney Disease Revenue, (2018-2023)
4.4 China Based Companies Drugs to Treat Chronic Kidney Disease Revenue and Market Share, 2018-2023
  4.4.1 China Based Drugs to Treat Chronic Kidney Disease Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Drugs to Treat Chronic Kidney Disease Revenue, (2018-2023)
4.5 Rest of World Based Drugs to Treat Chronic Kidney Disease Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Drugs to Treat Chronic Kidney Disease Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Drugs to Treat Chronic Kidney Disease Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Drugs to Treat Chronic Kidney Disease Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Calcimimetics
  5.2.2 Vitamin D
  5.2.3 Sterols
  5.2.4 Potassium Binders
  5.2.5 Calcium-Based Phosphate Binders
5.3 Market Segment by Type
  5.3.1 World Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2023)
  5.3.2 World Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029)
  5.3.3 World Drugs to Treat Chronic Kidney Disease Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Drugs to Treat Chronic Kidney Disease Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital Pharmacies
  6.2.2 Online Pharmacies
  6.2.3 Retail Pharmacies
6.3 Market Segment by Application
  6.3.1 World Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2023)
  6.3.2 World Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029)
  6.3.3 World Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Pfizer Inc.
  7.1.1 Pfizer Inc. Details
  7.1.2 Pfizer Inc. Major Business
  7.1.3 Pfizer Inc. Drugs to Treat Chronic Kidney Disease Product and Services
  7.1.4 Pfizer Inc. Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Pfizer Inc. Recent Developments/Updates
  7.1.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Details
  7.2.2 Johnson & Johnson Major Business
  7.2.3 Johnson & Johnson Drugs to Treat Chronic Kidney Disease Product and Services
  7.2.4 Johnson & Johnson Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Johnson & Johnson Recent Developments/Updates
  7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 AbbVie Inc.
  7.3.1 AbbVie Inc. Details
  7.3.2 AbbVie Inc. Major Business
  7.3.3 AbbVie Inc. Drugs to Treat Chronic Kidney Disease Product and Services
  7.3.4 AbbVie Inc. Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 AbbVie Inc. Recent Developments/Updates
  7.3.6 AbbVie Inc. Competitive Strengths & Weaknesses
7.4 Bayer AG
  7.4.1 Bayer AG Details
  7.4.2 Bayer AG Major Business
  7.4.3 Bayer AG Drugs to Treat Chronic Kidney Disease Product and Services
  7.4.4 Bayer AG Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Bayer AG Recent Developments/Updates
  7.4.6 Bayer AG Competitive Strengths & Weaknesses
7.5 Novartis AG
  7.5.1 Novartis AG Details
  7.5.2 Novartis AG Major Business
  7.5.3 Novartis AG Drugs to Treat Chronic Kidney Disease Product and Services
  7.5.4 Novartis AG Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Novartis AG Recent Developments/Updates
  7.5.6 Novartis AG Competitive Strengths & Weaknesses
7.6 Sanofi SA
  7.6.1 Sanofi SA Details
  7.6.2 Sanofi SA Major Business
  7.6.3 Sanofi SA Drugs to Treat Chronic Kidney Disease Product and Services
  7.6.4 Sanofi SA Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Sanofi SA Recent Developments/Updates
  7.6.6 Sanofi SA Competitive Strengths & Weaknesses
7.7 Bristol-Myers Squibb Company
  7.7.1 Bristol-Myers Squibb Company Details
  7.7.2 Bristol-Myers Squibb Company Major Business
  7.7.3 Bristol-Myers Squibb Company Drugs to Treat Chronic Kidney Disease Product and Services
  7.7.4 Bristol-Myers Squibb Company Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Bristol-Myers Squibb Company Recent Developments/Updates
  7.7.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.8 AstraZeneca plc
  7.8.1 AstraZeneca plc Details
  7.8.2 AstraZeneca plc Major Business
  7.8.3 AstraZeneca plc Drugs to Treat Chronic Kidney Disease Product and Services
  7.8.4 AstraZeneca plc Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 AstraZeneca plc Recent Developments/Updates
  7.8.6 AstraZeneca plc Competitive Strengths & Weaknesses
7.9 Eli Lilly and Company
  7.9.1 Eli Lilly and Company Details
  7.9.2 Eli Lilly and Company Major Business
  7.9.3 Eli Lilly and Company Drugs to Treat Chronic Kidney Disease Product and Services
  7.9.4 Eli Lilly and Company Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Eli Lilly and Company Recent Developments/Updates
  7.9.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.10 C.H. Boehringer Sohn AG & Co. KG
  7.10.1 C.H. Boehringer Sohn AG & Co. KG Details
  7.10.2 C.H. Boehringer Sohn AG & Co. KG Major Business
  7.10.3 C.H. Boehringer Sohn AG & Co. KG Drugs to Treat Chronic Kidney Disease Product and Services
  7.10.4 C.H. Boehringer Sohn AG & Co. KG Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 C.H. Boehringer Sohn AG & Co. KG Recent Developments/Updates
  7.10.6 C.H. Boehringer Sohn AG & Co. KG Competitive Strengths & Weaknesses
7.11 Amgen Inc.
  7.11.1 Amgen Inc. Details
  7.11.2 Amgen Inc. Major Business
  7.11.3 Amgen Inc. Drugs to Treat Chronic Kidney Disease Product and Services
  7.11.4 Amgen Inc. Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Amgen Inc. Recent Developments/Updates
  7.11.6 Amgen Inc. Competitive Strengths & Weaknesses
7.12 Novo Nordisk A/S
  7.12.1 Novo Nordisk A/S Details
  7.12.2 Novo Nordisk A/S Major Business
  7.12.3 Novo Nordisk A/S Drugs to Treat Chronic Kidney Disease Product and Services
  7.12.4 Novo Nordisk A/S Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 Novo Nordisk A/S Recent Developments/Updates
  7.12.6 Novo Nordisk A/S Competitive Strengths & Weaknesses
7.13 Teva Pharmaceutical Industries Ltd.
  7.13.1 Teva Pharmaceutical Industries Ltd. Details
  7.13.2 Teva Pharmaceutical Industries Ltd. Major Business
  7.13.3 Teva Pharmaceutical Industries Ltd. Drugs to Treat Chronic Kidney Disease Product and Services
  7.13.4 Teva Pharmaceutical Industries Ltd. Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
  7.13.6 Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.14 Otsuka Pharmaceutical Co. Ltd.
  7.14.1 Otsuka Pharmaceutical Co. Ltd. Details
  7.14.2 Otsuka Pharmaceutical Co. Ltd. Major Business
  7.14.3 Otsuka Pharmaceutical Co. Ltd. Drugs to Treat Chronic Kidney Disease Product and Services
  7.14.4 Otsuka Pharmaceutical Co. Ltd. Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.14.5 Otsuka Pharmaceutical Co. Ltd. Recent Developments/Updates
  7.14.6 Otsuka Pharmaceutical Co. Ltd. Competitive Strengths & Weaknesses
7.15 Takeda Pharmaceutical Company Limited
  7.15.1 Takeda Pharmaceutical Company Limited Details
  7.15.2 Takeda Pharmaceutical Company Limited Major Business
  7.15.3 Takeda Pharmaceutical Company Limited Drugs to Treat Chronic Kidney Disease Product and Services
  7.15.4 Takeda Pharmaceutical Company Limited Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023)
  7.15.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
  7.15.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Drugs to Treat Chronic Kidney Disease Industry Chain
8.2 Drugs to Treat Chronic Kidney Disease Upstream Analysis
8.3 Drugs to Treat Chronic Kidney Disease Midstream Analysis
8.4 Drugs to Treat Chronic Kidney Disease Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Drugs to Treat Chronic Kidney Disease Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Drugs to Treat Chronic Kidney Disease Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Drugs to Treat Chronic Kidney Disease Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Drugs to Treat Chronic Kidney Disease Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Drugs to Treat Chronic Kidney Disease Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Drugs to Treat Chronic Kidney Disease Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Drugs to Treat Chronic Kidney Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Drugs to Treat Chronic Kidney Disease Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Drugs to Treat Chronic Kidney Disease Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Drugs to Treat Chronic Kidney Disease Players in 2022
Table 12. World Drugs to Treat Chronic Kidney Disease Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Drugs to Treat Chronic Kidney Disease Company Evaluation Quadrant
Table 14. Head Office of Key Drugs to Treat Chronic Kidney Disease Player
Table 15. Drugs to Treat Chronic Kidney Disease Market: Company Product Type Footprint
Table 16. Drugs to Treat Chronic Kidney Disease Market: Company Product Application Footprint
Table 17. Drugs to Treat Chronic Kidney Disease Mergers & Acquisitions Activity
Table 18. United States VS China Drugs to Treat Chronic Kidney Disease Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Drugs to Treat Chronic Kidney Disease Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Drugs to Treat Chronic Kidney Disease Companies, Headquarters (States, Country)
Table 21. United States Based Companies Drugs to Treat Chronic Kidney Disease Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Drugs to Treat Chronic Kidney Disease Revenue Market Share (2018-2023)
Table 23. China Based Drugs to Treat Chronic Kidney Disease Companies, Headquarters (Province, Country)
Table 24. China Based Companies Drugs to Treat Chronic Kidney Disease Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Drugs to Treat Chronic Kidney Disease Revenue Market Share (2018-2023)
Table 26. Rest of World Based Drugs to Treat Chronic Kidney Disease Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Drugs to Treat Chronic Kidney Disease Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Drugs to Treat Chronic Kidney Disease Revenue Market Share (2018-2023)
Table 29. World Drugs to Treat Chronic Kidney Disease Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Drugs to Treat Chronic Kidney Disease Market Size by Type (2018-2023) & (USD Million)
Table 31. World Drugs to Treat Chronic Kidney Disease Market Size by Type (2024-2029) & (USD Million)
Table 32. World Drugs to Treat Chronic Kidney Disease Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Drugs to Treat Chronic Kidney Disease Market Size by Application (2018-2023) & (USD Million)
Table 34. World Drugs to Treat Chronic Kidney Disease Market Size by Application (2024-2029) & (USD Million)
Table 35. Pfizer Inc. Basic Information, Area Served and Competitors
Table 36. Pfizer Inc. Major Business
Table 37. Pfizer Inc. Drugs to Treat Chronic Kidney Disease Product and Services
Table 38. Pfizer Inc. Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Pfizer Inc. Recent Developments/Updates
Table 40. Pfizer Inc. Competitive Strengths & Weaknesses
Table 41. Johnson & Johnson Basic Information, Area Served and Competitors
Table 42. Johnson & Johnson Major Business
Table 43. Johnson & Johnson Drugs to Treat Chronic Kidney Disease Product and Services
Table 44. Johnson & Johnson Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Johnson & Johnson Recent Developments/Updates
Table 46. Johnson & Johnson Competitive Strengths & Weaknesses
Table 47. AbbVie Inc. Basic Information, Area Served and Competitors
Table 48. AbbVie Inc. Major Business
Table 49. AbbVie Inc. Drugs to Treat Chronic Kidney Disease Product and Services
Table 50. AbbVie Inc. Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. AbbVie Inc. Recent Developments/Updates
Table 52. AbbVie Inc. Competitive Strengths & Weaknesses
Table 53. Bayer AG Basic Information, Area Served and Competitors
Table 54. Bayer AG Major Business
Table 55. Bayer AG Drugs to Treat Chronic Kidney Disease Product and Services
Table 56. Bayer AG Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Bayer AG Recent Developments/Updates
Table 58. Bayer AG Competitive Strengths & Weaknesses
Table 59. Novartis AG Basic Information, Area Served and Competitors
Table 60. Novartis AG Major Business
Table 61. Novartis AG Drugs to Treat Chronic Kidney Disease Product and Services
Table 62. Novartis AG Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Novartis AG Recent Developments/Updates
Table 64. Novartis AG Competitive Strengths & Weaknesses
Table 65. Sanofi SA Basic Information, Area Served and Competitors
Table 66. Sanofi SA Major Business
Table 67. Sanofi SA Drugs to Treat Chronic Kidney Disease Product and Services
Table 68. Sanofi SA Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Sanofi SA Recent Developments/Updates
Table 70. Sanofi SA Competitive Strengths & Weaknesses
Table 71. Bristol-Myers Squibb Company Basic Information, Area Served and Competitors
Table 72. Bristol-Myers Squibb Company Major Business
Table 73. Bristol-Myers Squibb Company Drugs to Treat Chronic Kidney Disease Product and Services
Table 74. Bristol-Myers Squibb Company Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Bristol-Myers Squibb Company Recent Developments/Updates
Table 76. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 77. AstraZeneca plc Basic Information, Area Served and Competitors
Table 78. AstraZeneca plc Major Business
Table 79. AstraZeneca plc Drugs to Treat Chronic Kidney Disease Product and Services
Table 80. AstraZeneca plc Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. AstraZeneca plc Recent Developments/Updates
Table 82. AstraZeneca plc Competitive Strengths & Weaknesses
Table 83. Eli Lilly and Company Basic Information, Area Served and Competitors
Table 84. Eli Lilly and Company Major Business
Table 85. Eli Lilly and Company Drugs to Treat Chronic Kidney Disease Product and Services
Table 86. Eli Lilly and Company Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Eli Lilly and Company Recent Developments/Updates
Table 88. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 89. C.H. Boehringer Sohn AG & Co. KG Basic Information, Area Served and Competitors
Table 90. C.H. Boehringer Sohn AG & Co. KG Major Business
Table 91. C.H. Boehringer Sohn AG & Co. KG Drugs to Treat Chronic Kidney Disease Product and Services
Table 92. C.H. Boehringer Sohn AG & Co. KG Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. C.H. Boehringer Sohn AG & Co. KG Recent Developments/Updates
Table 94. C.H. Boehringer Sohn AG & Co. KG Competitive Strengths & Weaknesses
Table 95. Amgen Inc. Basic Information, Area Served and Competitors
Table 96. Amgen Inc. Major Business
Table 97. Amgen Inc. Drugs to Treat Chronic Kidney Disease Product and Services
Table 98. Amgen Inc. Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Amgen Inc. Recent Developments/Updates
Table 100. Amgen Inc. Competitive Strengths & Weaknesses
Table 101. Novo Nordisk A/S Basic Information, Area Served and Competitors
Table 102. Novo Nordisk A/S Major Business
Table 103. Novo Nordisk A/S Drugs to Treat Chronic Kidney Disease Product and Services
Table 104. Novo Nordisk A/S Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Novo Nordisk A/S Recent Developments/Updates
Table 106. Novo Nordisk A/S Competitive Strengths & Weaknesses
Table 107. Teva Pharmaceutical Industries Ltd. Basic Information, Area Served and Competitors
Table 108. Teva Pharmaceutical Industries Ltd. Major Business
Table 109. Teva Pharmaceutical Industries Ltd. Drugs to Treat Chronic Kidney Disease Product and Services
Table 110. Teva Pharmaceutical Industries Ltd. Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 112. Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 113. Otsuka Pharmaceutical Co. Ltd. Basic Information, Area Served and Competitors
Table 114. Otsuka Pharmaceutical Co. Ltd. Major Business
Table 115. Otsuka Pharmaceutical Co. Ltd. Drugs to Treat Chronic Kidney Disease Product and Services
Table 116. Otsuka Pharmaceutical Co. Ltd. Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Otsuka Pharmaceutical Co. Ltd. Recent Developments/Updates
Table 118. Takeda Pharmaceutical Company Limited Basic Information, Area Served and Competitors
Table 119. Takeda Pharmaceutical Company Limited Major Business
Table 120. Takeda Pharmaceutical Company Limited Drugs to Treat Chronic Kidney Disease Product and Services
Table 121. Takeda Pharmaceutical Company Limited Drugs to Treat Chronic Kidney Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Drugs to Treat Chronic Kidney Disease Upstream (Raw Materials)
Table 123. Drugs to Treat Chronic Kidney Disease Typical Customers

LIST OF FIGURE

Figure 1. Drugs to Treat Chronic Kidney Disease Picture
Figure 2. World Drugs to Treat Chronic Kidney Disease Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Drugs to Treat Chronic Kidney Disease Total Market Size (2018-2029) & (USD Million)
Figure 4. World Drugs to Treat Chronic Kidney Disease Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Drugs to Treat Chronic Kidney Disease Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Drugs to Treat Chronic Kidney Disease Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Drugs to Treat Chronic Kidney Disease Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Drugs to Treat Chronic Kidney Disease Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Drugs to Treat Chronic Kidney Disease Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Drugs to Treat Chronic Kidney Disease Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Drugs to Treat Chronic Kidney Disease Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Drugs to Treat Chronic Kidney Disease Revenue (2018-2029) & (USD Million)
Figure 13. Drugs to Treat Chronic Kidney Disease Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029) & (USD Million)
Figure 16. World Drugs to Treat Chronic Kidney Disease Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029) & (USD Million)
Figure 18. China Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029) & (USD Million)
Figure 23. India Drugs to Treat Chronic Kidney Disease Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Drugs to Treat Chronic Kidney Disease by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Drugs to Treat Chronic Kidney Disease Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Drugs to Treat Chronic Kidney Disease Markets in 2022
Figure 27. United States VS China: Drugs to Treat Chronic Kidney Disease Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Drugs to Treat Chronic Kidney Disease Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Drugs to Treat Chronic Kidney Disease Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Drugs to Treat Chronic Kidney Disease Market Size Market Share by Type in 2022
Figure 31. Calcimimetics
Figure 32. Vitamin D
Figure 33. Sterols
Figure 34. Potassium Binders
Figure 35. Calcium-Based Phosphate Binders
Figure 36. World Drugs to Treat Chronic Kidney Disease Market Size Market Share by Type (2018-2029)
Figure 37. World Drugs to Treat Chronic Kidney Disease Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Drugs to Treat Chronic Kidney Disease Market Size Market Share by Application in 2022
Figure 39. Hospital Pharmacies
Figure 40. Online Pharmacies
Figure 41. Retail Pharmacies
Figure 42. Drugs to Treat Chronic Kidney Disease Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source